D. Nixon

发表

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy.

A. Trkola, J. Moore, D. Ho, 1999, The Journal of clinical investigation.

The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

G. M. Ortiz, D. Nixon, S. Bonhoeffer, 2001, AIDS.

Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions.

G. M. Ortiz, D. Nixon, L. Kostrikis, 2002, AIDS.

Structured antiretroviral treatment interruptions in chronically HIV-1-infected subjects

D. Montefiori, G. M. Ortiz, D. Nixon, 2001, Proceedings of the National Academy of Sciences of the United States of America.

Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection

G. M. Ortiz, D. Nixon, S. Bonhoeffer, 2000, AIDS.

Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy.

D. Nixon, S. M. Donahoe, P. Haslett, 2000, The Journal of infectious diseases.

Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption.

G. M. Ortiz, D. Nixon, J. Heymann, 2000, The Journal of infectious diseases.

Sequential Broadening of CTL Responses in Early HIV-1 Infection Is Associated with Viral Escape

D. Nixon, F. Hecht, A. McMichael, 2007, PloS one.

Telescope: Characterization of the retrotranscriptome by accurate estimation of transposable element expression

M. Bendall, M. Pérez‐Losada, K. Crandall, 2019, PLoS computational biology.

Nine‐color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric approach

D. Nixon, J. Altman, M. Roederer, 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Detection of T lymphocytes specific for human endogenous retrovirus K (HERV-K) in patients with seminoma.

G. M. Ortiz, D. Nixon, P. Kuebler, 2006, AIDS research and human retroviruses.

Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

M A Nowak, M. Nowak, D. Ho, 1998, Science.

HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function

Douglas D. Richman, Tao Dong, Victor Appay, 2000, The Journal of experimental medicine.

Comparison of the ELISPOT and cytokine flow cytometry assays for the enumeration of antigen-specific T cells.

Elizabeth Sinclair, Jeffrey N. Martin, D. Nixon, 2003, Journal of immunological methods.

Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity.

X M Li, D. Nixon, P. Kuebler, 1996, Vaccine.

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

Charles R. M. Bangham, Sarah Rowland-Jones, Andrew J. McMichael, 1991, Nature.

TGF-β Sustains Tumor Progression through Biochemical and Mechanical Signal Transduction

D. Nixon, C. Brantner, A. Popratiloff, 2018, Cancers.

Selective Loss of Innate CD4+ Vα24 Natural Killer T Cells in Human Immunodeficiency Virus Infection

D. Nixon, R. Grant, J. K. Sandberg, 2002, Journal of Virology.

Human Endogenous Retrovirus Expression Is Upregulated in the Breast Cancer Microenvironment of HIV Infected Women: A Pilot Study

M. Bendall, M. Soares, D. Nixon, 2020, Frontiers in Oncology.

Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.

A. Jha, D. Nixon, L. Lanier, 2012, Blood.

Disease Severity KIR 2 DL 3 , NKG 2 C , and NKp 46 Correlates Uninfected Children and Their Expression of Degranulation Compared to HIV-1-Exposed HIV-1-Infected Children Exhibit Less Natural Killer Cells in Perinatally

Fennelly, D. Nixon, J. Glenn, 2007 .

Elevated frequency of IFN-γ producing NK cells following Influenza

D. Nixon, F. Hecht, L. Lanier, 2007 .

Vaccination against Endogenous Retrotransposable Element Consensus Sequences Does Not Protect Rhesus Macaques from SIVsmE660 Infection and Replication

D. Nixon, M. Ostrowski, E. Rakasz, 2014, PloS one.

Factors associated with attitudes towards HIV cure research among transgender women and travestis: a cross-sectional survey in São Paulo, Brazil

D. Nixon, M. Magnus, E. Kallás, 2020, BMJ Open.

cell-mediated cytotoxicity Tim-3 marks human natural killer cell maturation and suppresses

A. Jha, D. Nixon, L. Lanier, 2012 .

Cutting Edge: KIR3DS1, a Gene Implicated in Resistance to Progression to AIDS, Encodes a DAP12-Associated Receptor Expressed on NK Cells That Triggers NK Cell Activation1

D. Nixon, L. Lanier, D. Rosen, 2007, The Journal of Immunology.

Invariant natural killer T (iNKT) cell exhaustion in sarcoidosis

D. Nixon, L. Koth, J. Snyder-Cappione, 2013, European journal of immunology.

Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization

E. Paoletti, A. Hill, G. Dougan, 1996, European journal of immunology.

Telomere length and human hippocampal neurogenesis

D. Nixon, T. Powell, S. Thuret, 2020, Neuropsychopharmacology.

A Comprehensive Ex Vivo Functional Analysis of Human NKT Cells Reveals Production of MIP1-α and MIP1-β, a Lack of IL-17, and a Th1-Bias in Males

Jennifer E. Snyder-Cappione, Douglas F. Nixon, D. Nixon, 2010, PloS one.

Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression

D. Nixon, F. Hecht, J. K. Sandberg, 2009, AIDS.

LINE-1 Retrotransposable Elem ent DNA Accumulates in HIV-1-

A. Buzdin, D. Nixon, M. Ostrowski, 2013 .

CD7 Is a Differentiation Marker That Identifies Multiple CD8 T Cell Effector Subsets1

D. Nixon, J. K. Sandberg, E. Aandahl, 2003, The Journal of Immunology.

CD 7 Is a Differentiation Marker That Identifies Multiple CD 8 T Cell Effector Subsets 1

D. Nixon, J. K. Sandberg, E. Aandahl, 2003 .

Schizophrenia risk from locus-specific human endogenous retroviruses

M. Bendall, K. Crandall, C. Troakes, 2019 .

Dynamic Regulation of Host Restriction Factor Expression over the Course of HIV-1 Infection In Vivo

D. Nixon, F. Hecht, S. Pillai, 2014, Journal of Virology.

Generation of CD3+CD8low Thymocytes in the HIV Type 1-Infected Thymus1

D. Nixon, J. K. Sandberg, J. McCune, 2002, The Journal of Immunology.

Human Endogenous Retrovirus Expression Is Associated with Head and Neck Cancer and Differential Survival

M. Bendall, M. Pérez‐Losada, K. Crandall, 2020, Viruses.

Repurposing FDA-Approved Drugs for COVID-19 Using a Data-Driven Approach

D. Nixon, T. Powell, L. P. Iñiguez, 2020 .

Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting.

B. Walker, D. Kuritzkes, J. Martinez-Picado, 2019, The lancet. HIV.

The human IL-15 superagonist ALT-803 directs SIV-specific CD8+ T cells into B-cell follicles.

D. Nixon, A. Legasse, E. Connick, 2018, Blood advances.

Age but not disease progression defines CD4+ and CD8+ T stem cell memory levels in human retroviral infections: contrasting effects of HTLV-1 and HIV-1

D. Nixon, M. Roederer, S. Ribeiro, 2018, bioRxiv.

A Fashi Lymphoproliferative Phenotype Reveals Non-Apoptotic Fas Signaling in HTLV-1-Associated Neuroinflammation

D. Nixon, A. Vandamme, R. Liblau, 2017, Front. Immunol..

Allatostatin C modulates nociception and immunity in Drosophila

D. Nixon, I. Eleftherianos, N. Bachtel, 2018, Scientific Reports.

A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis.

P. Klenerman, S. Furlan, D. Nixon, 2001, Journal of immunological methods.

Inhibition of Antigen-Specific T Cell Proliferation and Cytokine Production by Protein Kinase A Type I1

D. Nixon, P. Haslett, E. Aandahl, 2002, Journal of Immunology.

Cytotoxic T-cell recognition of HIV proteins and peptides.

D. Nixon, A. McMichael, 1991, AIDS.

Rapid Progressing Allele HLA-B35 Px Restricted Anti-HIV-1 CD8+ T Cells Recognize Vestigial CTL Epitopes

D. Nixon, M. Ostrowski, F. Hecht, 2010, PloS one.

The cytotoxic T cell response to HIV

D. Nixon, 1992 .

Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27.

D. Nixon, A. McMichael, J. Rothbard, 1990, International immunology.

Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides.

D. Nixon, P. Kuebler, W. Koff, 1996, Vaccine.

Cytotoxic T cell induction with ratchet peptide libraries.

D. Nixon, P. Kuebler, 1996, Vaccine.

Human Endogenous Retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods

D. Nixon, M. Ostrowski, R. B. Jones, 2013, Journal of Negative Results in BioMedicine.

Human Endogenous Retrovirus K106 (HERV-K106) Was Infectious after the Emergence of Anatomically Modern Humans

A. Jha, Jeffrey N. Martin, D. Nixon, 2011, PloS one.

Cross-Sectional Dating of Novel Haplotypes of HERV-K 113 and HERV-K 115 Indicate These Proviruses Originated in Africa before Homo sapiens

Emily C. Storm, A. Jha, Jeffrey N. Martin, 2009, Molecular biology and evolution.

Human immunodeficiency virus variants that escape cytotoxic T-cell recognition.

S. Rowland-Jones, D. Nixon, R. Phillips, 1992, AIDS research and human retroviruses.

Antiretroviral drug activity and potential for pre-exposure prophylaxis against COVID-19 and HIV infection

D. Nixon, T. Powell, C. Ormsby, 2020, Journal of biomolecular structure & dynamics.

MAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications

D. Nixon, D. Paquin-Proulx, A. Segurado, 2017, PloS one.

Latent Mycobacterium tuberculosis Infection Is Associated With a Higher Frequency of Mucosal-Associated Invariant T and Invariant Natural Killer T Cells

D. Nixon, D. Paquin-Proulx, S. O’Connor, 2018, Front. Immunol..

Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells.

D. Nixon, J. M. Chapman, F. F. Melo, 2007, The Journal of infectious diseases.

Heterologous vaccine interventions: boosting immunity against future pandemics

D. Nixon, N. Hupert, D. Marín-Hernández, 2021, Molecular Medicine.

Bacteroides are associated with GALT iNKT cell function and reduction of microbial translocation in HIV-1 infection

D. Nixon, L. Loh, S. Lynch, 2016, Mucosal Immunology.

Multidrug-resistant, dual-tropic HIV-1 and rapid progression

D. Nixon, A. Karlsson, S. Deeks, 2005, The Lancet.

Regulation of T Cell Responses in the Developing Human Fetus1

Jeff E. Mold, D. Nixon, J. McCune, 2006, The Journal of Immunology.

Invariant natural killer T cells developing in the human fetus accumulate and mature in the small intestine

D. Nixon, L. Loh, J. Michaëlsson, 2014, Mucosal Immunology.

CD4+CD25+ regulatory T cells in HIV infection.

D. Nixon, E. Aandahl, J. Michaëlsson, 2005, Microbes and infection.

Conferral of Enhanced Natural Killer Cell Function by KIR3DS1 in Early Human Immunodeﬁciency Virus Type 1 Infection (cid:1)

D. Nixon, F. Hecht, J. Oksenberg, 2008 .

Conferral of Enhanced Natural Killer Cell Function by KIR3DS1 in Early Human Immunodeficiency Virus Type 1 Infection

D. Nixon, F. Hecht, J. Oksenberg, 2008, Journal of Virology.

Dominant effector memory characteristics, capacity for dynamic adaptive expansion, and sex bias in the innate Vα24 NKT cell compartment

D. Nixon, N. Bhardwaj, J. Sandberg, 2003, European journal of immunology.

Methods for Detection of Antigen-Specific T Cells by Enzyme-Linked Immunospot Assay (ELISPOT)

D. Nixon, B. Shacklett, 2006 .

Evaluation of a lipopeptide immunogen as a therapeutic in HIV type 1-seropositive individuals.

D. Nixon, N. Letvin, W. Koff, 2000, AIDS research and human retroviruses.

FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV‐1 infection

D. Nixon, F. Hecht, G. Spotts, 2008, Journal of leukocyte biology.

Composition and Function of T Cell Subpopulations Are Slow to Change Despite Effective Antiretroviral Treatment of HIV Disease

Jeffrey N. Martin, D. Nixon, J. McCune, 2014, PloS one.

Transcriptome-wide association study of HIV-1 acquisition identifies HERC1 as a susceptibility gene

D. Nixon, T. Powell, R. Furler, 2022, iScience.

Test, treat, and cure.

D. Nixon, G. Simon, R. Raposo, 2015, Journal of acquired immune deficiency syndromes.

Strong Human Endogenous Retrovirus-Speciﬁc T Cell Responses Are Associated with Control of HIV-1 in Chronic Infection (cid:1) †‡

Jeffrey N. Martin, D. Nixon, M. Ostrowski, 2011 .

Human Immunodeﬁciency Virus Type 1 (HIV-1)-Speciﬁc CD8 (cid:1) T EMRA Cells in Early Infection Are Linked to Control of HIV-1 Viremia and Predict the Subsequent Viral Load Set Point (cid:1)

P. Klenerman, D. Nixon, F. Hecht, 2007 .

A Decreased Frequency of Regulatory T Cells in Patients with Common Variable Immunodeficiency

D. Nixon, L. Ndhlovu, K. Carvalho, 2009, PloS one.

Ia antigens on non-lymphoid tissues their origins and functions.

J. Frelinger, D. Nixon, J. Ting, 1982, Immunology today.

Development of innate CD4+ α-chain variable gene segment 24 (Vα24) natural killer T cells in the early human fetal thymus is regulated by IL-7

D. Nixon, C. Stoddart, F. Brilot, 2004 .

Cytotoxicity on HIV-1 Mediates Antibody-Dependent Cellular Ancestral Endogenous Virus Glycoproteins Cutting Edge: An Antibody Recognizing

Jeffrey N. Martin, D. Nixon, S. Deeks, 2014 .

Histoarchitectural Deterioration of Lymphoid Tissues in HIV-1 Infection and in Aging.

D. Nixon, G. Reyes-Terán, R. Furler, 2019, AIDS research and human retroviruses.

GROUP-SPECIFIC COMPONENT AND HIV INFECTION

D. Nixon, B. Boneu, C. Rizza, 1987, The Lancet.

Cytotoxic T lymphocyte epitopes shared between HIV-1, HIV-2, and SIV.

D. Nixon, A. McMichael, F. Gotch, 1993, Journal of medical primatology.

T Lymphocytes +Cytolytic Effector Molecules in Human CD8 Functional Heterogeneity of Cytokines and

D. Nixon, N. Fast, J. Sandberg, 2001 .

Restriction of HIV-1 infection in sickle cell trait

A. Adimora, K. Anastos, Tatiana Ammosova, 2021, Blood Advances.

Herpes simplex virus and HIV-1: deciphering viral synergy.

D. Nixon, Rex G. Cheng, 2009, The Lancet. Infectious diseases.

Generation of CD3 CD8 Thymocytes in the HIV Type 1-Infected Thymus

D. Nixon, J. McCune, M. Keir, 2002 .

Generation of CD 3 CD 8 low Thymocytes in the HIV Type 1-Infected Thymus 1

D. Nixon, J. McCune, M. Keir, 2002 .

CD57 Expression and Cytokine Production by T Cells in Lesional and Unaffected Skin from Patients with Psoriasis

T. Maurer, D. Nixon, W. Liao, 2013, PloS one.

CD57 deﬁnes a functionally distinct population of mature NK cells in the human CD56 dim CD16 (cid:1) NK-cell subset

H. Pircher, D. Nixon, L. Lanier, 2010 .

Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection

A. Jha, D. Nixon, J. M. Chapman, 2008, AIDS.

R5 Human Immunodeficiency Virus Type 1 (HIV-1) Replicates More Efficiently in Primary CD4+ T-Cell Cultures Than X4 HIV-1

D. Nixon, J. Heymann, B. Schweighardt, 2004, Journal of Virology.

R5 Human Immunodeﬁciency Virus Type 1 (HIV-1) Replicates More Efﬁciently in Primary CD4 (cid:1) T-Cell Cultures Than X4 HIV-1

D. Nixon, J. Heymann, B. Schweighardt, 2004 .

D. Nixon, L. Ndhlovu, M. T. Giret, 2012, PloS one.

HIV-1 Vpu Interference with Innate Cell-mediated Immune Mechanisms

D. Nixon, M. Moll, S. Andersson, 2012, Current HIV research.

Increased number and function of natural killer cells in human immunodeficiency virus 1‐positive subjects co‐infected with herpes simplex virus 2

D. Nixon, L. Lanier, J. M. Chapman, 2010, Immunology.

HIV-1-specific T Cell-dependent natural killer (NK) cell activation: major contribution by NK cells to interferon-gamma production in response to HIV-1 antigens.

D. Nixon, F. Hecht, J. Michaëlsson, 2009, AIDS research and human retroviruses.

IL13Rα2 expression identifies tissue‐resident IL‐22‐producing PLZF+ innate T cells in the human liver

J. Berzofsky, D. Nixon, E. Melum, 2018, European journal of immunology.

HIV-gag-specific cytotoxic T lymphocytes.

D. Nixon, A. McMichael, 1989, Research in immunology.

Acquisition of innate-like microbial reactivity in mucosal tissues during human fetal MAIT-cell development

D. Nixon, L. Loh, E. Leeansyah, 2014, Nature Communications.

CD56 neg CD16 + NK cells are activated mature NK cells with impaired effector function during HIV-1 infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2014 .

NK cells are activated mature NK cells with impaired effector function during HIV-1 infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2014 .

Involvement of Cisgender and Transgender Individuals in Studies on the Impact of Hormonal Therapy on COVID-19

D. Nixon, Jez L. Marston, R. Wozniak, 2020, AIDS patient care and STDs.

Associations between Antibodies to a Panel of Plasmodium falciparum Specific Antigens and Response to Sub-Optimal Antimalarial Therapy in Kampala, Uganda

A. Jha, P. Rosenthal, D. Nixon, 2012, PloS one.

Lower numbers of circulating natural killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV‐1) associated neurological disease

A. Jha, D. Nixon, E. Murphy, 2009, Clinical and experimental immunology.

Immune activation in amniotic fluid from Zika virus–associated microcephaly

D. Nixon, A. Tanuri, C. C. Cardoso, 2017, Annals of neurology.

Biomimetic Placenta-Fetus Model Demonstrating Maternal–Fetal Transmission and Fetal Neural Toxicity of Zika Virus

J. Fisher, D. Nixon, M. Santoro, 2018, Annals of Biomedical Engineering.

Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral Therapy.

R. Apps, D. Nixon, R. B. Jones, 2019, AIDS research and human retroviruses.

Human interleukin‐34‐derived macrophages have increased resistance to HIV‐1 infection

D. Nixon, L. Grayfer, D. Paquin-Proulx, 2018, Cytokine.

IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.

D. Nixon, D. Paquin-Proulx, G. Beckerle, 2017, JCI insight.

Development of innate CD4+ alpha-chain variable gene segment 24 (Valpha24) natural killer T cells in the early human fetal thymus is regulated by IL-7.

D. Nixon, C. Stoddart, F. Brilot, 2004, Proceedings of the National Academy of Sciences of the United States of America.

T Cells Target APOBEC3 Proteins in Human Immunodeficiency Virus Type 1-Infected Humans and Simian Immunodeficiency Virus-Infected Indian Rhesus Macaques

Jeffrey N. Martin, D. Nixon, M. Ostrowski, 2013, Journal of Virology.

Innate Invariant NKT Cell Recognition of HIV-1–Infected Dendritic Cells Is an Early Detection Mechanism Targeted by Viral Immune Evasion

D. Nixon, C. Wheelock, A. Checa, 2016, The Journal of Immunology.

IL-2 Immunotherapy to Recently HIV-1 Infected Adults Maintains the Numbers of IL-17 Expressing CD4+ T (TH17) Cells in the Periphery

A. Jha, D. Nixon, F. Hecht, 2010, Journal of Clinical Immunology.

Title IL-2 Immunotherapy to Recently HIV-1 Infected Adults Maintains the Numbers of IL-17 Expressing CD 4 + T ( TH 17 ) Cells in the Periphery Permalink

A. Jha, D. Nixon, F. Hecht, 2010 .

Restriction Factor Expression in Vertically Infected Children Living With HIV-1.

D. Nixon, C. Ormsby, A. Wiznia, 2020, The Pediatric infectious disease journal.

Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany

D. Nixon, N. Hupert, D. Marín-Hernández, 2021, Human vaccines & immunotherapeutics.

Decay Kinetics of HIV-1 Specific T Cell Responses in Vertically HIV-1 Exposed Seronegative Infants

D. Nixon, P. Kuebler, E. Kallás, 2012, Front. Immun..

Lower numbers of natural killer T cells in HIV‐1 and Mycobacterium leprae co‐infected patients

D. Nixon, P. Haslett, K. Carvalho, 2012, Immunology.

MAIT cells are activated in acute Dengue virus infection and after in vitro Zika virus infection

D. Nixon, D. Paquin-Proulx, J. Levi, 2018, PLoS neglected tropical diseases.

The frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesis

D. Nixon, J. M. Chapman, J. Michaëlsson, 2008, BMC Immunology.

Comprehensive Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-β Response in HTLV-1-Associated Neuroinflammation

D. Nixon, R. Khouri, T. Dierckx, 2018, Front. Microbiol..

HIV-1 replication and latency are balanced by mTOR-driven cell metabolism

D. Nixon, J. Crater, Robert L. Furler O’Brien, 2022, Frontiers in Cellular and Infection Microbiology.

Specific human endogenous retroviruses predict metastatic potential in uveal melanoma

M. Bendall, D. Nixon, A. Shoushtari, 2022, JCI insight.

Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection

R. Kaul, A. Jha, D. Nixon, 2008, The Journal of experimental medicine.

Engineered Antigen-Specific T Cells Secreting Broadly Neutralizing Antibodies: Combining Innate and Adaptive Immune Response against HIV

D. Nixon, P. Hanley, C. Bollard, 2020, Molecular therapy. Methods & clinical development.

Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID‐19 deaths in Italy

D. Nixon, R. Schwartz, D. Marín-Hernández, 2020, Journal of medical virology.

Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave

D. Nixon, N. Hupert, R. Águas, 2022, Proceedings of the National Academy of Sciences.

Telescope: Characterization of the retrotranscriptome by accurate estimation of transposable element expression

Keith A. Crandall, Marcos Pérez-Losada, Matthew L. Bendall, 2018, bioRxiv.

Off-Target Effect of Activation of NF-κB by HIV Latency Reversal Agents on Transposable Elements Expression

M. Soares, D. Nixon, L. P. Iñiguez, 2022, Viruses.

Dicer-2 Regulates Resistance and Maintains Homeostasis against Zika Virus Infection in Drosophila

D. Nixon, I. Eleftherianos, D. Paquin-Proulx, 2018, The Journal of Immunology.

Next-Generation Human Cerebral Organoids as Powerful Tools To Advance NeuroHIV Research

H. Fine, D. Nixon, L. Ndhlovu, 2021, mBio.

Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion

D. Nixon, J. Kalil, D. Paquin-Proulx, 2016, Medicine.

Vaccination with Cancer- and HIV Infection-Associated Endogenous Retrotransposable Elements Is Safe and Immunogenic

B. Pierce, D. Nixon, M. Ostrowski, 2012, The Journal of Immunology.

Correction: p16INK4a Expression and Immunologic Aging in Chronic HIV Infection

D. Nixon, S. Deeks, J. Kalil, 2017, PloS one.

p16INK4a Expression and Immunologic Aging in Chronic HIV Infection

Susan Pereira Ribeiro, Jorge Kalil, D. Nixon, 2016, PloS one.

Elevated Frequency of Gamma Interferon-Producing NK Cells in Healthy Adults Vaccinated against Influenza Virus

D. Nixon, F. Hecht, L. Lanier, 2007, Clinical and Vaccine Immunology.

Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface

D. Nixon, A. Caliendo, T. Flanigan, 2000, AIDS.

Maternal Alloantigens Promote the Development of Tolerogenic Fetal Regulatory T Cells in Utero

Jeff E. Mold, D. Nixon, J. McCune, 2008, Science.

An Antigenic Threshold for Maintaining Human Immunodeficiency Virus Type 1-specific Cytotoxic T Lymphocytes

D. Ho, D. Nixon, S. Bonhoeffer, 2000, Molecular medicine.

Correlates of nontransmission in US women at high risk of human immunodeficiency virus type 1 infection through sexual exposure.

J. Skurnick, S. Vermund, D. Nixon, 2002, The Journal of infectious diseases.

Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.

D. Nixon, L. Lanier, A. Cappione, 2009, Blood.

CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset.

H. Pircher, D. Nixon, L. Lanier, 2010, Blood.

LINE-1 Retrotransposable Element DNA Accumulates in HIV-1-Infected Cells

A. Buzdin, D. Nixon, M. Ostrowski, 2013, Journal of Virology.

HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.

Nabil F. Faruk, D. Nixon, M. Ostrowski, 2012, The Journal of clinical investigation.

Nucleoside Analogue Reverse Transcriptase Inhibitors Differentially Inhibit Human LINE-1 Retrotransposition

D. Nixon, M. Ostrowski, R. B. Jones, 2008, PloS one.

Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers.

P. Klenerman, D. Nixon, E. Barnes, 2000, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

Newly Exerted T Cell Pressures on Mutated Epitopes following Transmission Help Maintain Consensus HIV-1 Sequences

D. Nixon, F. Hecht, A. Karlsson, 2015, PloS one.

MicroRNAs 145 and 148a Are Upregulated During Congenital Zika Virus Infection

D. Nixon, A. Tanuri, M. Ribeiro-Alves, 2019, ASN neuro.

Psoriasis Patients Are Enriched for Genetic Variants That Protect against HIV-1 Disease

G. McVean, M. Carrington, A. Bowcock, 2012, PLoS genetics.

Functional Heterogeneity of Cytokines and Cytolytic Effector Molecules in Human CD8+ T Lymphocytes1

D. Nixon, N. Fast, J. Sandberg, 2001, The Journal of Immunology.

Requirement of Mature Dendritic Cells for Efficient Activation of Influenza A-Specific Memory CD8+ T Cells1

D. Nixon, S. M. Donahoe, V. Cerundolo, 2000, The Journal of Immunology.

Protective Effect of Human Endogenous Retrovirus K dUTPase Variants on Psoriasis Susceptibility

A. Bowcock, D. Nixon, P. Kuebler, 2012, The Journal of investigative dermatology.

Endogenous Reverse Transcriptase Inhibition Attenuates TLR5-Mediated Inflammation

M. Bendall, D. Nixon, Jez L. Marston, 2023, mBio.

A field guide to endogenous retrovirus regulatory networks.

M. Bendall, D. Nixon, Elizabeth A. Lawrence, 2022, Molecular cell.

Optimization of methods to assess human mucosal T-cell responses to HIV infection.

Julie Elliott, O. Yang, D. Nixon, 2003, Journal of immunological methods.

Locus-Specific Characterization of Human Endogenous Retrovirus Expression in Prostate, Breast, and Colon Cancers

M. Bendall, K. Crandall, D. Nixon, 2021, Cancer Research.

Hallmarks of Retroelement Expression in T-Cells Treated With HDAC Inhibitors

M. Soares, D. Nixon, L. P. Iñiguez, 2021, Frontiers in Virology.

Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry

D. Nixon, R. Schwartz, T. Powell, 2021, Molecular medicine.

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

R. Steinman, M. Dhodapkar, D. Nixon, 1999, The Journal of clinical investigation.

Effects of Cellular Activation on Anti-HIV-1 Restriction Factor Expression Profile in Primary Cells

D. Montefiori, D. Nixon, S. Pillai, 2013, Journal of Virology.

Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells

R. Siliciano, B. Walker, D. Nixon, 2018, The Journal of clinical investigation.

Broadly Immunogenic HLA Class I Supertype-Restricted Elite CTL Epitopes Recognized in a Diverse Population Infected with Different HIV-1 Subtypes1

Morten Nielsen, Ole Lund, Rasmus Gustafsson, 2008, The Journal of Immunology.

HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides

D. Nixon, A. McMichael, A. Townsend, 1988, Nature.

Influence of HAART on Alternative Reading Frame Immune Responses over the Course of HIV-1 Infection

Jeffrey N. Martin, D. Nixon, W. Koff, 2012, PloS one.

HTLV-1 Tax Specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications

A. Jha, D. Nixon, M. Ostrowski, 2011, Retrovirology.

HTLV-1 Tax Specific CD8+ T Cells Express Low Levels of Tim-3 in HTLV-1 Infection: Implications for Progression to Neurological Complications

A. Jha, D. Nixon, M. Ostrowski, 2011, PLoS neglected tropical diseases.

Human CD4+ CD25+ Regulatory T Cells Control T-Cell Responses to Human Immunodeficiency Virus and Cytomegalovirus Antigens

D. Nixon, F. Hecht, E. Aandahl, 2004, Journal of Virology.

An Effective AIDS Vaccine Based on Live Attenuated Vesicular Stomatitis Virus Recombinants

David Montefiori, John K. Rose, Douglas F. Nixon, 2001, Cell.

Targeting of conserved gag-epitopes in early HIV infection is associated with lower plasma viral load and slower CD4(+) T cell depletion.

O. Lund, M. Larsen, D. Nixon, 2013, AIDS research and human retroviruses.

Immune Escape Mutations Detected Within HIV-1 Epitopes Associated With Viral Control During Treatment Interruption

T. Wrin, C. Petropoulos, D. Nixon, 2010, Journal of acquired immune deficiency syndromes.

Antiretroviral Drug Therapy Alters the Profile of Human Immunodeficiency Virus Type 1-Specific T-Cell Responses and Shifts the Immunodominant Cytotoxic T-Lymphocyte Response from Gag to Pol

D. Nixon, A. Karlsson, J. M. Chapman, 2007, Journal of Virology.

Infection Is Critically Influenced by Age and Children with Vertically Acquired HIV-1 HIV-Specific CD8+ T Cell Function in

D. Nixon, J. Barbour, H. Spiegel, 2013 .

T cell immunity in acute HIV-1 infection.

D. Nixon, H. Streeck, 2010, The Journal of infectious diseases.

Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8+ TEMRA Cells in Early Infection Are Linked to Control of HIV-1 Viremia and Predict the Subsequent Viral Load Set Point

P. Klenerman, D. Nixon, F. Hecht, 2007, Journal of Virology.

Higher frequency of HIV-1-specific T cell immune responses in African American children vertically infected with HIV-1.

D. Nixon, J. Barbour, A. Wiznia, 2005, The Journal of infectious diseases.

HIV-Specific CD8+ T Cell Function in Children with Vertically Acquired HIV-1 Infection Is Critically Influenced by Age and the State of the CD4+ T Cell Compartment1

S. Furlan, D. Nixon, J. Barbour, 2003, The Journal of Immunology.

T Cell Compartment + the State of the CD 4 Infection Is Critically Influenced by Age and Children with Vertically Acquired HIV-1 T Cell Function in + HIV-Specific CD 8

S. Furlan, D. Nixon, Michael, 2003 .

The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children.

D. Nixon, W. Borkowsky, R. Chandwani, 2000, The Journal of infectious diseases.

The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses.

J. Moore, D. Ho, J. Binley, 1999, The Journal of infectious diseases.

A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides

S. Rowland-Jones, D. Nixon, A. McMichael, 1993, European journal of immunology.

Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection

P. J. Norris, D. Nixon, L. Lanier, 2011, Proceedings of the National Academy of Sciences.

Longitudinal and cross-sectional analysis of cytotoxic T lymphocyte responses and their relationship to vertical human immunodeficiency virus transmission. ARIEL Project Investigators.

B. Walker, B. Korber, D. Ho, 1998, The Journal of infectious diseases.

Longitudinal and Cross-Sectional Analysis of Cytotoxic T Lymphocyte (CTL) Responses and their Relationship to Vertical HIV Transmission

B. Walker, B. Korber, D. Ho, 1998 .

Longitudinal and Cross-Sectional Analysis of Cytotoxic T Lymphocyte Responses and Their Relationship to Vertical Human Immunodeficiency Virus Transmission

B. Walker, B. Korber, D. Ho, 1998 .

Evidence that CD32a does not mark the HIV-1 latent reservoir

R. Apps, D. Nixon, M. Ackerman, 2018, Nature.

T lymphocyte responses against human parvovirus B19: small virus, big response.

Annette Oxenius, P. Klenerman, D. Nixon, 2002, Pathologie-biologie.

Comparison of restimulation methods to elicit SIV specific cytotoxic T-lymphocytes (CTL) in vitro: Staphylococcal enterotoxin B (SEB) provides a novel method for the quantification of SIV specific CTL precursors.

D. Nixon, X. Jin, S. M. Donahoe, 1999, Immunology letters.

Tregs control the development of symptomatic West Nile virus infection in humans and mice.

Rachel E. Owen, Marion C Lanteri, A. Rudensky, 2009, The Journal of clinical investigation.

Direct Ex Vivo Measurement of CD8+T-Lymphocyte Responses to Human Parvovirus B19

P. Klenerman, D. Nixon, A. Oxenius, 2001, Journal of Virology.

HLA-C downregulation by HIV-1 adapts to host HLA genotype

M. Carrington, Jeffrey N. Martin, R. Apps, 2018, PLoS pathogens.

Phenotypic, Functional, and Kinetic Parameters Associated with Apparent T-Cell Control of Human Immunodeficiency Virus Replication in Individuals with and without Antiretroviral Treatment

Jeffrey N. Martin, D. Nixon, J. McCune, 2005, Journal of Virology.

HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant

S. Rowland-Jones, D. Nixon, A. McMichael, 1993, The Lancet.

Strong HIV-1-Specific T Cell Responses in HIV-1-Exposed Uninfected Infants and Neonates Revealed after Regulatory T Cell Removal

D. Nixon, J. M. Chapman, É. Ono, 2006, PloS one.

The CD8+ Memory Stem T Cell (TSCM) Subset Is Associated with Improved Prognosis in Chronic HIV-1 Infection

D. Nixon, S. Deeks, J. Kalil, 2014, Journal of Virology.

Potentially Exposed but Uninfected Individuals Produce Cytotoxic and Polyfunctional Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses Which Can Be Defined to the Epitope Level

L. Grohskopf, S. Buchbinder, D. Nixon, 2008, Clinical and Vaccine Immunology.

Dual Pressure from Antiretroviral Therapy and Cell-Mediated Immune Response on the Human Immunodeficiency Virus Type 1 Protease Gene

Jeffrey N. Martin, G. M. Ortiz, D. Nixon, 2003, Journal of Virology.

Residual Viral Replication during Antiretroviral Therapy Boosts Human Immunodeficiency Virus Type 1-Specific CD8+ T-Cell Responses in Subjects Treated Early after Infection

G. M. Ortiz, D. Nixon, M. Markowitz, 2002, Journal of Virology.

High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfections.

D. Nixon, X. Jin, S. Bonhoeffer, 2000, The Journal of infectious diseases.

Increased expression of intrinsic antiviral genes in HLA‐B*57‐positive individuals

D. Nixon, P. Kuebler, S. Pillai, 2013, Journal of leukocyte biology.

Immunodominance of HIV-1 Specific CD8+ T-Cell Responses Is Related to Disease Progression Rate in Vertically Infected Adolescents

D. Nixon, P. Kuebler, C. Willberg, 2011, PloS one.

The CD4−CD8− MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool

D. Nixon, M. Betts, L. Loh, 2018, Proceedings of the National Academy of Sciences.

Loss of Circulating Mucosal-Associated Invariant T Cells in Common Variable Immunodeficiency Is Associated with Immune Activation and Loss of Eomes and PLZF

D. Nixon, J. Kalil, D. Paquin-Proulx, 2017, ImmunoHorizons.

Immune Activation and Loss of Eomes and PLZF Common Variable Immunodeficiency Is Associated with Loss of Circulating Mucosal-Associated Invariant T Cells in

D. Nixon, J. Kalil, D. Paquin-Proulx, 2017 .

Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy

M. Nowak, D. Ho, Y. Cao, 1999, Journal of Virology.

The behavioral, cellular and immune mediators of HIV-1 acquisition: New insights from population genetics

M. Hotopf, G. Breen, C. Lewis, 2020, Scientific Reports.

Type 1 -Defective HIV nef Patients Infected with Activity in Sydney Blood Bank Cohort (HIV)-Specific Cytotoxic T-Lymphocyte Strong Human Immunodeficiency Virus

S. Rowland-Jones, D. Nixon, M. Demoitié, 2014 .

CD8 T cell effector maturation in HIV-1-infected children.

S. Furlan, D. Nixon, A. Karlsson, 2006, Virology.

Strong Human Immunodeficiency Virus (HIV)-Specific Cytotoxic T-Lymphocyte Activity in Sydney Blood Bank Cohort Patients Infected with nef-Defective HIV Type 1

S. Rowland-Jones, D. Nixon, M. Demoitié, 1999, Journal of Virology.

Variability of HIV-1 Genomes among Children and Adolescents from São Paulo, Brazil

D. Nixon, E. Sabino, E. Kallás, 2013, PloS one.

Presence of human immunodeficiency virus-1-specific CD4 and CD8 cellular immune responses in children with full or partial virus suppression.

D. Nixon, L. Montaner, V. Maino, 2003, The Journal of infectious diseases.

Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children.

D. Nixon, W. Borkowsky, G. Ogg, 1999, The Journal of infectious diseases.

Human Endogenous Retrovirus Expression Is Inversely Associated with Chronic Immune Activation in HIV-1 Infection

Steven G. Deeks, Mario A. Ostrowski, R. Brad Jones, 2012, PloS one.

Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus.

D. Nixon, A. Spivak, V. Planelles, 2018, AIDS research and human retroviruses.

T‐cell strategies in AIDS vaccines: MHC‐restricted T‐cell responses to HIV proteins

D. Nixon, K. Mills, A. McMichael, 1989, AIDS.

Psoriasis risk SNPs and their association with HIV-1 control.

D. Nixon, F. Hecht, W. Liao, 2017, Human immunology.

Changes in CD4+ T-Cell Differentiation Phenotype During Structured Treatment Interruption in Patients With Chronic HIV-1 Infection

S. Furlan, G. M. Ortiz, D. Nixon, 2003, Journal of acquired immune deficiency syndromes.

Natural Killer Cells in Perinatally HIV-1-Infected Children Exhibit Less Degranulation Compared to HIV-1-Exposed Uninfected Children and Their Expression of KIR2DL3, NKG2C, and NKp46 Correlates with Disease Severity1

Jakob Michaëlsson, Lewis L Lanier, D. Nixon, 2007, The Journal of Immunology.

Expression profile of host restriction factors in HIV-1 elite controllers

D. Nixon, M. David, E. Sinclair, 2013, Retrovirology.

Direct measurement of CD4+ and CD8+ T-cell responses to CMV in HIV-1-infected subjects.

D. Nixon, S. M. Donahoe, G. Ogg, 2001, Virology.

Direct Measurement of CD41 and CD81 T-Cell Responses to CMV in HIV-1-Infected Subjects

D. Nixon, S. M. Donahoe, G. Ogg, 2001 .

High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals.

D. Nixon, A. McMichael, N. Alp, 1990, International immunology.

Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment.

D. Nixon, F. Hecht, A. Sönnerborg, 2004, Blood.

T-cell Responses in Individuals Infected with Zika Virus and in Those Vaccinated Against Dengue Virus

D. Nixon, E. Kallás, D. Paquin-Proulx, 2017, Pathogens & immunity.

SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements

M. Bendall, D. Nixon, C. Feschotte, 2021, JCI insight.

Transcriptional Errors in Human Immunodeficiency Virus Type 1 Generate Targets for T-Cell Responses

Jeffrey N. Martin, D. Nixon, F. Hecht, 2009, Clinical and Vaccine Immunology.

ELISPOT cell rescue.

D. Nixon, B. Schweighardt, A. Karlsson, 2004, Journal of immunological methods.

Dendritic cell amplification of HIV type 1-specific CD8+ T cell responses in exposed, seronegative heterosexual women.

J. Skurnick, R. Means, D. Nixon, 2002, AIDS Research and Human Retroviruses.

Cellular and humoral antigenic epitopes in HIV and SIV.

D. Nixon, G. Ogg, K. Broliden, 1992, Immunology.

Trans-activation, post-transcriptional maturation, and induction of antibodies to HERV-K (HML-2) envelope transmembrane protein in HIV-1 infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2014, Retrovirology.

The impact of telomere shortening on human hippocampal neurogenesis: Implications for cognitive function and psychiatric disorder risk

D. Nixon, T. Powell, S. Thuret, 2020, bioRxiv.

Modulating APOBEC expression enhances DNA vaccine immunogenicity

D. Nixon, J. Kalil, E. Cunha-Neto, 2015, Immunology and cell biology.

Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target

M. Soares, D. Nixon, Gislaine Curty, 2020, Viruses.

Enhanced ELISPOT detection of antigen-specific T cell responses from cryopreserved specimens with addition of both IL-7 and IL-15--the Amplispot assay.

D. Nixon, L. Kestens, B. Shacklett, 2002, Journal of immunological methods.

Evidence that CD32a does not mark the HIV-1 latent reservoir

R. Apps, D. Nixon, M. Ackerman, 2018, Nature.

CD32 does not mark the HIV-1/SIV latent reservoir

R. Apps, D. Nixon, J. Ananworanich, 2017 .

Amplification of low-frequency antiviral CD8 T cell responses using autologous dendritic cells

D. Nixon, P. Haslett, N. Bhardwaj, 2002, AIDS.

HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform

D. Nixon, P. Hanley, C. Bollard, 2019, Molecular therapy. Methods & clinical development.

T-cell therapies for HIV: Preclinical successes and current clinical strategies.

D. Nixon, C. Bollard, R. B. Jones, 2016, Cytotherapy.

Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia

Z. Grossman, Jeffrey N. Martin, D. Nixon, 2004, AIDS.

Interleukin‐10‐secreting T cells define a suppressive subset within the HIV‐1‐specific T‐cell population

A. Jha, D. Nixon, K. Torgersen, 2009, European journal of immunology.

Nine‐color flow cytometry for accurate measurement of T cell subsets and cytokine responses. Part II: Panel performance across different instrument platforms

L. Beckett, D. Nixon, J. Altman, 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Antiviral gene expression in psoriasis

S. Arron, D. Nixon, P. Kuebler, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Expansion in CD39+ CD4+ Immunoregulatory T Cells and Rarity of Th17 Cells in HTLV-1 Infected Patients Is Associated with Neurological Complications

D. Nixon, L. Ndhlovu, S. Sanabani, 2013, PLoS neglected tropical diseases.

T Cells + Memory CD8 Efficient Activation of Influenza A-Specific Requirement of Mature Dendritic Cells for

D. Nixon, S. M. Donahoe, V. Cerundolo, 2000 .

Isolation of cytomegalovirus-specific cytotoxic T-lymphocytes from gut-associated lymphoid tissue (GALT) of HIV type 1-infected subjects.

D. Nixon, A. King, G. Ogg, 2000, AIDS research and human retroviruses.

Characterization of HIV-1-specific cytotoxic T lymphocytes expressing the mucosal lymphocyte integrin CD103 in rectal and duodenal lymphoid tissue of HIV-1-infected subjects.

D. Nixon, A. King, G. Ogg, 2000, Virology.

Abundant Expression of Granzyme A, but Not Perforin, in Granules of CD8+ T Cells in GALT: Implications for Immune Control of HIV-1 Infection1

D. Nixon, M. Jacobson, J. Andersson, 2004, The Journal of Immunology.

Biomimetic Placenta-Fetus Model Demonstrating Maternal–Fetal Transmission and Fetal Neural Toxicity of Zika Virus

J. Fisher, D. Nixon, M. Santoro, 2018, Annals of Biomedical Engineering.

Brain Ia antigens have a bone marrow origin

L. Weiner, J. Frelinger, D. Nixon, 2004, Immunogenetics.

A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.

R. Steinman, D. Nixon, X. Jin, 1999, AIDS.

Poorly soluble peptides can mimic authentic ELISPOT responses.

D. Nixon, K. Page-Shafer, B. Shacklett, 2004, Journal of immunological methods.

Lithium treatment and human hippocampal neurogenesis

D. Nixon, T. Powell, S. Thuret, 2021, Translational Psychiatry.

Human Immunodeficiency Virus Type 1- and Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Persist at High Frequency for Prolonged Periods in the Absence of Circulating Peripheral CD4+ T Cells

D. Nixon, S. M. Donahoe, W. Borkowsky, 2000, Journal of Virology.

Differentiation and functional regulation of human fetal NK cells.

D. Nixon, L. Loh, N. Marquardt, 2013, The Journal of clinical investigation.

Limited Magnitude and Breadth in the HLA‐A2‐Restricted CD8 T‐Cell Response to Nef in Children with Vertically Acquired HIV‐1 Infection

D. Nixon, L. Montaner, E. Papasavvas, 2004, Scandinavian journal of immunology.

Extreme immunotherapy: emergency immunology to defeat pandemics

D. Nixon, N. Hupert, D. Marín-Hernández, 2021, Molecular medicine.

T Cell Responses to Human Endogenous Retroviruses in HIV-1 Infection

Naveed Anwar, R. Brad Jones, D. Nixon, 2007, PLoS pathogens.

A simple and rapid magnetic bead separation technique for the isolation of tetramer-positive virus-specific CD8 T cells.

D. Nixon, G. Ogg, A. McDermott, 2001, AIDS.

Identification of subdominant cytotoxic T lymphocyte epitopes encoded by autologous HIV type 1 sequences, using dendritic cell stimulation and computer-driven algorithm.

D. Nixon, X. Jin, L. Zhang, 2000, AIDS research and human retroviruses.

Trafficking of Human Immunodeficiency Virus Type 1-Specific CD8+ T Cells to Gut-Associated Lymphoid Tissue during Chronic Infection

D. Nixon, M. Jacobson, N. Stollman, 2003, Journal of Virology.

Boosting of SIV-specific T cell responses in rhesus macaques that resist repeated intravaginal challenge with SIVmac251.

D. Nixon, B. Ling, R. Veazey, 2002, AIDS research and human retroviruses.

Identification of Human Endogenous Retrovirus-Specific T Cell Responses in Vertically HIV-1-Infected Subjects

D. Nixon, M. Ostrowski, R. B. Jones, 2011, Journal of Virology.

Strong Human Endogenous Retrovirus-Specific T Cell Responses Are Associated with Control of HIV-1 in Chronic Infection

Jeffrey N. Martin, D. Nixon, M. Ostrowski, 2011, Journal of Virology.

Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers

Jeffrey N. Martin, D. Nixon, F. Hecht, 2017, Retrovirology.

Inhibition of Human Immunodeficiency Virus Type 1 gp120 Presentation to CD4 T Cells by Antibodies Specific for the CD4 Binding Domain of gp120

S. Zolla-Pazner, M. Gorny, D. Nixon, 2001, Journal of Virology.

Diminished humoral responses against and reduced gene expression levels of human endogenous retrovirus-K (HERV-K) in psoriasis

S. Arron, D. Nixon, W. Liao, 2014, Journal of Translational Medicine.

Human Endogenous Retrovirus K(HML-2) Gag- and Env-Specific T-Cell Responses Are Infrequently Detected in HIV-1-Infected Subjects Using Standard Peptide Matrix-Based Screening

Theo M. Luider, Gabor Gyenes, Mario A. Ostrowski, 2011, Clinical and Vaccine Immunology.

CD 56 negCD 16 + NK cells are activated mature NK cells with impaired effector function during HIV-1 infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2014 .

CD56negCD16+ NK cells are activated mature NK cells with impaired effector function during HIV-1 infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2013, Retrovirology.

Human T-lymphotropic virus 1, breastfeeding, and antiretroviral therapy.

D. Nixon, F. Leal, Marcin Michniowski, 2015, AIDS research and human retroviruses.

The Calm Mouse: An Animal Model of Stress Reduction

D. Nixon, F. Hecht, P. Bacchetti, 2012, Molecular medicine.

New observations on CD8 cell responses.

D. Nixon, E. Aandahl, J. Sandberg, 2003, AIDS.

The Immunologists’ Guide to Pandemic Preparedness

D. Nixon, N. Hupert, D. Marín-Hernández, 2020, Trends in Immunology.

Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity.

Jeffrey N. Martin, D. Nixon, F. Hecht, 2012, Blood.

Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2.

D. Nixon, F. Hecht, L. Lanier, 2008, The Journal of infectious diseases.

Two-step recognition of HIV-1 DNA in the cytosol

D. Nixon, Nicholas Dopkins, 2022, Trends in Microbiology.

How human endogenous retroviruses interact with the microbiota in health and disease.

M. Bendall, D. Nixon, Jez L. Marston, 2022, Trends in microbiology.

Rational Peptide Selection To Detect Human Immunodeficiency Virus Type 1-Specific T-Cell Responses under Resource-Limited Conditions

D. Nixon, C. Willberg, S. Pillai, 2007, Clinical and Vaccine Immunology.

Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection.

D. Nixon, F. Hecht, J. Levy, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Single-Cell, Phosphoepitope-Specific Analysis Demonstrates Cell Type- and Pathway-Specific Dysregulation of Jak/STAT and MAPK Signaling Associated with In Vivo Human Immunodeficiency Virus Type 1 Infection

G. Nolan, D. Nixon, Andrew W. Lee, 2008, Journal of Virology.

Immunity to HIV-1 Is Influenced by Continued Natural Exposure to Exogenous Virus

D. Nixon, R. Grant, C. Willberg, 2008, PLoS pathogens.

Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+ T-Cell Activation.

D. Nixon, P. Kuebler, R. Grant, 2016, The Journal of infectious diseases.

IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells

Jeffrey N. Martin, P. Haaland, D. Nixon, 2006, AIDS research and therapy.

Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans

John P. Moore, D. Nixon, P. Klasse, 2021, Science Advances.

Highly Effective Control of an AIDS Virus Challenge in Macaques by Using Vesicular Stomatitis Virus and Modified Vaccinia Virus Ankara Vaccine Vectors in a Single-Boost Protocol

P. Earl, B. Moss, D. Montefiori, 2004, Journal of Virology.

Booster vaccines for COVID-19 vaccine breakthrough cases?

D. Nixon, R. Schwartz, L. Ndhlovu, 2022, The Lancet.

Montelukast drug activity and potential against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)

D. Nixon, T. Powell, R. Duarte, 2020, Journal of Medical Virology.

Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trial

D. Glidden, D. Nixon, P. Kuebler, 2015, Proceedings of the National Academy of Sciences.

Comments on “coinfection of SARS‐CoV‐2 and HIV in a patient in Wuhan city, China”

D. Nixon, 2020, Journal of Medical Virology.

Association of Differentiation State of CD4+ T Cells and Disease Progression in HIV-1 Perinatally Infected Children

D. Nixon, P. Kuebler, C. Willberg, 2012, PloS one.

Molecular tracking of an Human Immunodeficiency Virus nef specific cytotoxic T-cell clone shows persistence of clone-specific T-cell receptor DNA but not mRNA following early combination antiretroviral therapy.

D. Ho, Y. Cao, D. Nixon, 1999, Immunology letters.

Skewed Distribution of Circulating Activated Natural Killer T (NKT) Cells in Patients with Common Variable Immunodeficiency Disorders (CVID)

Jennifer E. Snyder-Cappione, Douglas F. Nixon, D. Nixon, 2010, PloS one.

Publisher Correction: Evidence that CD32a does not mark the HIV-1 latent reservoir

R. Apps, D. Nixon, A. Tsibris, 2018, Nature.

The Psychiatric Risk Gene NT5C2 Regulates Adenosine Monophosphate-Activated Protein Kinase Signaling and Protein Translation in Human Neural Progenitor Cells

R. Murray, G. Breen, C. Troakes, 2019, Biological Psychiatry.

A Plea for Justice for Jailed Medical Workers

A. Trkola, R. Schooley, M. Lederman, 2006, Science.

Treatment interruption in chronic HIV-1 infection: does it deliver?

D. Nixon, C. Willberg, 2007, Current opinion in HIV and AIDS.

Partial treatment interruption of protease inhibitors augments HIV-specific immune responses in vertically infected pediatric patients

D. Nixon, M. Davenport, S. Deeks, 2005, AIDS.

Differential Expression of CD96 Surface Molecule Represents CD8+ T Cells with Dissimilar Effector Function during HIV-1 Infection

Jeffrey N. Martin, D. Nixon, F. Hecht, 2012, PloS one.

Effects of a mindfulness‐based weight loss intervention in adults with obesity: A randomized clinical trial

E. Epel, D. Nixon, F. Hecht, 2016, Obesity.

Direct measurement of CD8+ T cell responses in macaques infected with simian immunodeficiency virus.

K. Metzner, D. Nixon, S. M. Donahoe, 2000, Virology.

Psychiatric risk gene NT5C2 regulates protein translation in human neural progenitor cells

R. Murray, G. Breen, C. Troakes, 2018, bioRxiv.

The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy.

J. Moore, J. Binley, G. M. Ortiz, 2000, The Journal of infectious diseases.

Relevance of HIV-1-Specific CD4+ Helper T-Cell Responses During Structured Treatment Interruptions in Patients With CD4+ T-Cell Nadir Above 400/mm3

G. M. Ortiz, D. Nixon, C. Fagard, 2004, Journal of acquired immune deficiency syndromes.

Transposable elements and Alzheimer’s disease pathogenesis

D. Nixon, Jez L. Marston, T. Evering, 2022, Trends in Neurosciences.

Enriched environment and stress exposure influence splenic B lymphocyte composition

D. Nixon, F. Hecht, R. Palme, 2017, PloS one.

NK Cells and CD1d‐restricted NKT Cells Respond in Different Ways with Divergent Kinetics to IL‐2 Treatment in Primary HIV‐1 Infection

D. Nixon, G. Spotts, F. Hecht, 2011, Scandinavian journal of immunology.

Expansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2.

D. Nixon, F. Hecht, G. Spotts, 2006, Blood.

HIV-1-Specific CD4+ T Cell Responses in Chronically HIV-1 Infected Blippers on Antiretroviral Therapy in Relation to Viral Replication Following Treatment Interruption

D. Nixon, L. Montaner, E. Papasavvas, 2006, Journal of Clinical Immunology.

Rapid quantification of SIV-specific CD8 T cell responses with recombinant vaccinia virus ELISPOT or cytokine flow cytometry.

D. Nixon, L. Drohan, Walter J. Moretto, 2000, AIDS.

HTLV-1 Tax activates HIV-1 transcription in latency models.

D. Nixon, A. Tanuri, F. Leal, 2017, Virology.

Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection.

D. Nixon, R. Price, B. Shacklett, 2004, The Journal of infectious diseases.

Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques

J. Binley, K. Metzner, D. Nixon, 2006, Retrovirology.

Genetic risk for severe COVID‐19 correlates with lower inflammatory marker levels in a SARS‐CoV‐2‐negative cohort

M. Hotopf, G. Breen, D. Nixon, 2021, Clinical & translational immunology.

Skewed distribution of natural killer cells in psoriasis skin lesions

T. Maurer, D. Nixon, P. Kuebler, 2013, Experimental dermatology.

Spontaneous occurrence of photoageing-like phenotypes in the dorsal skin of old SAMP 1 mice , an oxidative stress model

T. Maurer, D. Nixon, P. Kuebler, 2012 .

T-cell strategies in AIDS vaccines

D. Nixon, A. McMichael, Mills Khg., 1989 .

The psychiatric risk gene NT5C2 regulates AMPK signalling 1 and protein translation in human neural progenitor cells

R. Murray, C. Troakes, D. Nixon, 2022 .

Environmental Enrichment Alters Splenic Immune Cell Composition and Enhances Secondary Influenza Vaccine Responses in Mice

D. Nixon, F. Hecht, R. Palme, 2014, Molecular medicine.

Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus.

David C Montefiori, Xia Jin, J. Binley, 2005, The Journal of general virology.

Evaluation of CD 8 + T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live , attenuated simian immunodeficiency virus

J. Binley, K. Metzner, D. Montefiori, 2005 .

HIV-1/HSV-2 Co-Infected Adults in Early HIV-1 Infection Have Elevated CD4+ T Cell Counts

D. Nixon, J. Barbour, K. Garrison, 2007, PloS one.

A novel human CD4+ T‐cell inducer subset with potent immunostimulatory properties

Marion C Lanteri, A. Jha, D. Nixon, 2009, European journal of immunology.

Simian immunodeficiency virus-specific cytotoxic T lymphocytes and protection against challenge in rhesus macaques immunized with a live attenuated simian immunodeficiency virus vaccine.

K. Metzner, D. Nixon, S. M. Donahoe, 2000, Virology.

HIV-1 Mediated Cortical Actin Disruption Mirrors ARP2/3 Defects Found in Primary T Cell Immunodeficiencies

D. Nixon, Robert L. Furler O’Brien, J. Crater, 2023, bioRxiv.

infection treated with interleukin-2 Expansion of CD1d-restricted NKT cells in patients with primary HIV-1

D. Nixon, F. Hecht, G. Spotts, 2013 .

Brief Report: HIV-1 gp120 T-Cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemoprophylaxis Trial

D. Nixon, P. Kuebler, R. Grant, 2016, Journal of acquired immune deficiency syndromes.

Anti-HERV-K (HML-2) capsid antibody responses in HIV elite controllers

Jeffrey N. Martin, D. Nixon, F. Hecht, 2017, Retrovirology.

The psychiatric risk gene NT5C2 regulates AMPK signalling

C. Troakes, D. Nixon, D. Srivastava, 2019 .

The behavioral, cellular and immune mediators of HIV-1 acquisition: New insights from population genetics

M. Hotopf, G. Breen, C. Lewis, 2020, Scientific Reports.

HIV‐specific cytotoxic T‐cell activity in an HIV‐exposed but uninfected infants

S. Rowland-Jones, D. Nixon, A. McMichael, 1993 .

Locus specific human endogenous retroviruses reveal new lymphoma subtypes

M. Bendall, E. Cesarman, D. Nixon, 2023, bioRxiv.

Cutting Edge: An Antibody Recognizing Ancestral Endogenous Virus Glycoproteins Mediates Antibody-Dependent Cellular Cytotoxicity on HIV-1–Infected Cells

Jeffrey N. Martin, D. Nixon, S. Deeks, 2014, The Journal of Immunology.

HLA-C downregulation by HIV-1 adapts to host HLA genotype

M. Carrington, Jeffrey N. Martin, R. Apps, 2018, PLoS pathogens.

Inversion of the V delta 1 to V delta 2 gamma delta T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion

D. Nixon, J. Kalil, D. Paquin-Proulx, 2016 .

HIV‐1 drug resistance prevalence, drug susceptibility and variant characterization in the Jacobi Medical Center paediatric cohort, Bronx, NY, USA

D. Nixon, Á. Holguín, M. Rosenberg, 2014, HIV medicine.

Nef-induced differential gene expression in primary CD4+ T cells following infection with HIV-1 isolates

O. Yang, Ayub Ali, D. Nixon, 2019, Virus Genes.

Nef-induced differential gene expression in primary CD4+ T cells following infection with HIV-1 isolates

O. Yang, Ayub Ali, D. Nixon, 2019, Virus genes.

The psychiatric risk gene NT5C2 regulates AMPK signalling 1 and protein translation in human neural progenitor cells

C. Troakes, D. Nixon, N. Bray, 2022 .

A History and Atlas of the Human CD4+ T Helper Cell

D. Nixon, D. Dunn, J. Crater, 2023, Biomedicines.

Psoriasis risk SNPs and their association with HIV-1 control.

D. Nixon, F. Hecht, W. Liao, 2017, Human immunology.

Lower numbers of natural killer T cells in HIV‐1 and Mycobacterium leprae co‐infected patients

D. Nixon, P. Haslett, K. Carvalho, 2012, Immunology.

Dynamic Regulation of Host Restriction Factor Expression over the Course of HIV-1 Infection In Vivo

D. Nixon, F. Hecht, S. Pillai, 2014, Journal of Virology.

IL13Rα2 expression identifies tissue‐resident IL‐22‐producing PLZF+ innate T cells in the human liver

J. Berzofsky, D. Nixon, E. Melum, 2018, European journal of immunology.

Is there a role for etravirine in patients with Nonnucleoside reverse transcriptase inhibitor resistance?

A. Jha, D. Nixon, J. M. Chapman, 2008, AIDS.

IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis.

D. Nixon, G. Beckerle, M. de Mulder Rougvie, 2017, JCI insight.

Interleukin‐10‐secreting T cells define a suppressive subset within the HIV‐1‐specific T‐cell population

A. Jha, D. Nixon, K. Torgersen, 2009, European journal of immunology.

Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.

D. Nixon, L. Lanier, A. Cappione, 2009, Blood.

The CD4−CD8− MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool

D. Nixon, M. Betts, L. Loh, 2018, Proceedings of the National Academy of Sciences.

Vaccination with Cancer- and HIV Infection-Associated Endogenous Retrotransposable Elements Is Safe and Immunogenic

B. Pierce, D. Nixon, M. Ostrowski, 2012, The Journal of Immunology.

Evolutionary History of the Proviruses HERV‐K 113 and HERV‐K 115

A. Jha, D. Nixon, S. Pillai, 2014 .

CTL induction using synthetic peptides delivered in emulsions--critical role of the formulation procedure.

D. Nixon, W. Koff, M. Singh, 1997, Vaccine.